Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 632 of 1,261
  1. US 9657023

    Polymorph of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  2. US 9657007

    Substituted aminopyrimidine compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  3. US 9656999

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  4. US 9657004

    Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use

    Agios Pharmaceuticals, Inc. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  5. US 9656993

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted May 23, 2017 · Expires May 18, 2037

    granted
  6. US 9655917

    Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

    Northwestern University · Granted May 23, 2017 · Expires May 18, 2037

    granted
  7. US 9655969

    Inhalable medicament comprising tiotropium

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  8. US 9655938

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  9. US 9655900

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 23, 2017 · Expires May 18, 2037

    granted
  10. US 9655366

    Volatile blends and the effects thereof on the navel orangeworm moth

    The United States of America, as represented by the Secretary of Agriculture · Granted May 23, 2017 · Expires May 18, 2037

    granted
  11. US 9655842

    Injectable non-aqueous compositions and methods of treating vascular disease

    Covidien LP · Granted May 23, 2017 · Expires May 18, 2037

    granted
  12. US 2017136004

    Opioid Agonist Antagonist Combinations

    ALKERMES PHARMA IRELAND LTD [IE] · Granted May 18, 2017 · Expires May 13, 2037

    granted
  13. US 9650391

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  14. US 9651562

    Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis

    The Regents of the University of California · Granted May 16, 2017 · Expires May 11, 2037

    granted
  15. US 9650256

    Cerium oxide-aluminosilicate tubes nanocomposite and method of preparation

    TOVARISTVO Z OBMEZHENOU VIDPOVIDALNISTU “NANOMEDTRAST” · Granted May 16, 2017 · Expires May 11, 2037

    granted
  16. US 9650648

    Methods and compositions for treatment of a genetic condition

    Sangamo Biosciences, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  17. US 9650381

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 16, 2017 · Expires May 11, 2037

    granted
  18. US 9650436

    Antibody based reagents that specifically recognize toxic oligomeric forms of tau

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 16, 2017 · Expires May 11, 2037

    granted
  19. US 9651462

    Method and system for sampling and separating submicron-sized particles based on density and/or size to detect the presence of a particular agent

    The United States of America as represented by the Secretary of the Army · Granted May 16, 2017 · Expires May 11, 2037

    granted
  20. US 9649291

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted May 16, 2017 · Expires May 11, 2037

    granted
  21. US 9650343

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 16, 2017 · Expires May 11, 2037

    granted
  22. US 9649320

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  23. US 9649364

    Methods for producing stable therapeutic formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  24. US 9649343

    Compositions and methods for transplantation of colon microbiota

    National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted May 16, 2017 · Expires May 11, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.